Potential impact of nicorandil on the pharmacodynamics of anti-angiogenic agents
Artículo
Acceso abierto
Artículo
DOAJ
Abstract Anti-angiogenic agents are widely used to treat solid tumors. We previously demonstrated that nicorandil, an angina pectoris medication, counteracted the effects of bevacizumab in a human mini-tumor model. To fu...
LCC LCC:Medicine; TENDOlNjaWVuY2U~Idioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access